LUXEMBOURG, January 26, 2026--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 12/01/2026 | FR0014000MR3 | 5 000 | 71.7101 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 13/01/2026 | FR0014000MR3 | 5 000 | 70.5398 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 14/01/2026 | FR0014000MR3 | 5 000 | 70.2815 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 15/01/2026 | FR0014000MR3 | 5 000 | 70.9660 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 16/01/2026 | FR0014000MR3 | 5 000 | 70.7250 | XPAR |
TOTAL | 25 000 | 70.8445 |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20260126423443/en/
Contacts
Eurofins